Free Trial

Federated Hermes Inc. Boosts Stock Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

DENTSPLY SIRONA logo with Medical background

Federated Hermes Inc. boosted its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 38.6% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 234,604 shares of the medical instruments supplier's stock after purchasing an additional 65,300 shares during the quarter. Federated Hermes Inc. owned about 0.12% of DENTSPLY SIRONA worth $3,505,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of XRAY. Mirae Asset Global Investments Co. Ltd. bought a new position in shares of DENTSPLY SIRONA during the 1st quarter valued at about $25,000. Colonial Trust Co SC bought a new position in shares of DENTSPLY SIRONA in the 4th quarter worth approximately $26,000. True Wealth Design LLC grew its holdings in DENTSPLY SIRONA by 866.7% in the fourth quarter. True Wealth Design LLC now owns 2,175 shares of the medical instruments supplier's stock worth $41,000 after purchasing an additional 1,950 shares during the period. Allworth Financial LP grew its stake in shares of DENTSPLY SIRONA by 175.8% in the first quarter. Allworth Financial LP now owns 3,949 shares of the medical instruments supplier's stock worth $54,000 after acquiring an additional 2,517 shares during the last quarter. Finally, Quarry LP raised its holdings in DENTSPLY SIRONA by 25.7% in the fourth quarter. Quarry LP now owns 3,816 shares of the medical instruments supplier's stock worth $72,000 after buying an additional 780 shares during the last quarter. Institutional investors own 95.70% of the company's stock.

Analyst Ratings Changes

A number of equities analysts have weighed in on XRAY shares. UBS Group decreased their target price on DENTSPLY SIRONA from $27.00 to $25.00 and set a "buy" rating for the company in a research report on Friday, May 9th. Piper Sandler decreased their price target on shares of DENTSPLY SIRONA from $20.00 to $16.00 and set a "neutral" rating on the stock in a research note on Wednesday, April 30th. Wall Street Zen raised DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a research note on Sunday, July 13th. Morgan Stanley lowered DENTSPLY SIRONA from an "overweight" rating to an "equal weight" rating and set a $14.00 target price for the company. in a research report on Tuesday, April 15th. Finally, Needham & Company LLC reissued a "hold" rating on shares of DENTSPLY SIRONA in a research note on Monday, July 21st. Ten equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the stock has a consensus rating of "Hold" and an average target price of $19.60.

Read Our Latest Stock Analysis on XRAY

DENTSPLY SIRONA Stock Down 2.6%

Shares of XRAY stock traded down $0.37 during mid-day trading on Wednesday, hitting $13.68. 5,608,192 shares of the stock traded hands, compared to its average volume of 2,913,575. The stock's fifty day moving average is $15.89 and its two-hundred day moving average is $16.02. The stock has a market cap of $2.73 billion, a P/E ratio of -3.01, a P/E/G ratio of 1.02 and a beta of 0.94. The company has a debt-to-equity ratio of 0.79, a current ratio of 1.10 and a quick ratio of 0.76. DENTSPLY SIRONA Inc. has a 52-week low of $12.16 and a 52-week high of $27.48.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last issued its quarterly earnings results on Thursday, May 8th. The medical instruments supplier reported $0.43 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.29 by $0.14. The business had revenue of $879.00 million for the quarter, compared to analyst estimates of $854.75 million. DENTSPLY SIRONA had a negative net margin of 24.42% and a positive return on equity of 14.31%. DENTSPLY SIRONA's revenue for the quarter was down 7.8% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.42 EPS. Equities analysts predict that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current year.

DENTSPLY SIRONA Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, July 11th. Investors of record on Friday, June 27th were given a dividend of $0.16 per share. The ex-dividend date was Friday, June 27th. This represents a $0.64 dividend on an annualized basis and a yield of 4.7%. DENTSPLY SIRONA's payout ratio is currently -14.10%.

DENTSPLY SIRONA Profile

(Free Report)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

See Also

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Should You Invest $1,000 in DENTSPLY SIRONA Right Now?

Before you consider DENTSPLY SIRONA, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.

While DENTSPLY SIRONA currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Overlooked AI Stocks That Chipmakers Can’t Live Without
Palantir & AMD Earnings: Massive Options Setups Ahead
3 Value Plays Set to Explode

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines